{
    "title": "Mechanisms of ovarian cancer metastasis: biochemical pathways.",
    "doc_id": "23109879",
    "writer": "Nakayama K",
    "year": "2012",
    "summary": "Ovarian cancer is the most lethal gynecologic malignancy. Despite advances in chemotherapy, the five-year survival rate of advanced ovarian cancer patients with peritoneal metastasis remains around 30%. ...This article reviews metastatic suppressor gen â€¦",
    "abstract": "Ovarian cancer is the most lethal gynecologic malignancy. Despite advances in chemotherapy, the five-year survival rate of advanced ovarian cancer patients with peritoneal metastasis remains around 30%. The most significant prognostic factor is stage, and most patients present at an advanced stage with peritoneal dissemination. There is often no clearly identifiable precursor lesion; therefore, the events leading to metastatic disease are poorly understood. This article reviews metastatic suppressor genes, the epithelial-mesenchymal transition (EMT), and the tumor microenvironment as they relate to ovarian cancer metastasis. Additionally, novel chemotherapeutic agents targeting the metastasis-related biochemical pathways are discussed.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/23109879/"
}